Export 24 results:
Author [ Title(Desc)] Type Year
Filters: Author is Wolff, Mark  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
I
N. Ali Goji, Nolan, C., Hill, H., Wolff, M., Noah, D. L., Williams, T. B., Rowe, T., and Treanor, J. J., Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant., J Infect Dis, vol. 198, no. 5, pp. 635-41, 2008.
L. A. Jackson, Patel, S. M., Swamy, G. K., Frey, S. E., C Creech, B., Munoz, F. M., Artal, R., Keitel, W. A., Noah, D. L., Petrie, C. Rodeheffer, Wolff, M., and Edwards, K. M., Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women., J Infect Dis, vol. 204, no. 6, pp. 854-63, 2011.
T. S Callahan, Wolff, M., Hill, H. R., and Edwards, K. M., Impact of body mass index on immunogenicity of pandemic H1N1 vaccine in children and adults., J Infect Dis, vol. 210, no. 8, pp. 1270-4, 2014.
L. R. Baden, Liu, J., Li, H., Johnson, J. A., Walsh, S. R., Kleinjan, J. A., Engelson, B. A., Peter, L., Abbink, P., Milner, D. A., Golden, K. L., Viani, K. L., Stachler, M. D., Chen, B. J., Pau, M. G., Weijtens, M., Carey, B. R., Miller, C. A., Swann, E. M., Wolff, M., Loblein, H., Seaman, M. S., Dolin, R., and Barouch, D. H., Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humans., J Infect Dis, vol. 211, no. 4, pp. 518-28, 2015.
P
W. H. Chen, Winokur, P. L., Edwards, K. M., Jackson, L. A., Wald, A., Walter, E. B., Noah, D. L., Wolff, M., and Kotloff, K. L., Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009., Vaccine, vol. 30, no. 28, pp. 4240-8, 2012.
S. E. Frey, Bernstein, D. I., Brady, R. C., Keitel, W. A., Sahly, H. El, Rouphael, N. Georges, Mulligan, M. J., Atmar, R. L., Edupuganti, S., Patel, S. M., Dickey, M., Graham, I., Anderson, E. L., Noah, D. L., Hill, H., Wolff, M., and Belshe, R. B., Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations., Vaccine, vol. 33, no. 1, pp. 163-73, 2015.
E. W. Hook, Behets, F., Van Damme, K., Ravelomanana, N., Leone, P., Seña, A. C., Martin, D., Langley, C., McNeil, L., and Wolff, M., A phase III equivalence trial of azithromycin versus benzathine penicillin for treatment of early syphilis., J Infect Dis, vol. 201, no. 11, pp. 1729-35, 2010.
A. C. Seña, Wolff, M., Martin, D. H., Behets, F., Van Damme, K., Leone, P., Langley, C., McNeil, L., and Hook, E. W., Predictors of serological cure and Serofast State after treatment in HIV-negative persons with early syphilis., Clin Infect Dis, vol. 53, no. 11, pp. 1092-9, 2011.
S
B. L. Rivoire, Groathouse, N. A., TerLouw, S., Neupane, K. Dev, Ranjit, C., Sapkota, B. Raj, Khadge, S., Kunwar, C. B., Kunwar, C. B., Macdonald, M., Hawksworth, R., Thapa, M. B., Hagge, D. A., Tibbals, M., Smith, C., Dube, T., She, D., Wolff, M., Zhou, E., Makhene, M., Mason, R., Sizemore, C., and Brennan, P. J., Safety and efficacy assessment of two new leprosy skin test antigens: randomized double blind clinical study., PLoS Negl Trop Dis, vol. 8, no. 5, p. e2811, 2014.
S. E. Frey, Bernstein, D. I., Gerber, M. A., Keyserling, H. L., Munoz, F. M., Winokur, P. L., Turley, C. B., Rupp, R. E., Hill, H., Wolff, M., Noah, D. L., Ross, A. C., Cress, G., and Belshe, R. B., Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations., J Infect Dis, vol. 206, no. 6, pp. 828-37, 2012.
D. I. Bernstein, Sahly, H. M. El, Keitel, W. A., Wolff, M., Simone, G., Segawa, C., Wong, S., Shelly, D., Young, N. S., and Dempsey, W., Safety and immunogenicity of a candidate parvovirus B19 vaccine., Vaccine, vol. 29, no. 43, pp. 7357-63, 2011.
J. J. Treanor, Campbell, J. D., Zangwill, K. M., Rowe, T., and Wolff, M., Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine., N Engl J Med, vol. 354, no. 13, pp. 1343-51, 2006.
R. B. Belshe, Frey, S. E., Graham, I., Mulligan, M. J., Edupuganti, S., Jackson, L. A., Wald, A., Poland, G., Jacobson, R., Keyserling, H. L., Spearman, P., Hill, H., and Wolff, M., Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant., J Infect Dis, vol. 203, no. 5, pp. 666-73, 2011.
F. M. Munoz, Jackson, L. A., Swamy, G. K., Edwards, K. M., Frey, S. E., Stephens, I., Ault, K., Winokur, P., Petrie, C. R., Wolff, M., Patel, S. M., and Keitel, W. A., Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women., Vaccine, vol. 36, no. 52, pp. 8054-8061, 2018.